Company Filing History:

6 out of 10,754

Basf Aktiengesellschaft

patents

1 out of 17

Basf Aktiengsellschaft

patents

Years Active: 1987-1997

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5663141 - Hirudin/polyalkylene glycol conjugates and hirudin muteins (1997-09-02),

2. 5102892 - 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared (1992-04-07),

3. 4999345 - Sulfonamide derivatives and drugs obtained therefrom (1991-03-12),

4. 4944943 - Mixture of a substance having thrombolytic activity and of an (1990-07-31),

5. 4845096 - Benzofuran derivatives and antiulcerogenic agents containing same (1989-07-04),

6. 4723039 - Phenylacetaldehydes substituted by basic groups, their preparation and (1988-02-02),

7. 4710496 - Pyrrol-1-ylphenyldihydropyridazinones, their preparation and their use (1987-12-01),

Title: Klaus Ruebsamen: Innovator in Pharmaceutical Chemistry

Introduction

Klaus Ruebsamen is a notable inventor based in Neustadt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug formulations. With a total of 7 patents to his name, Ruebsamen's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents are the "Hirudin/polyalkylene glycol conjugates" and "Hirudin muteins - 2-alkyl-4-arylmethylaminoquinolines." These patents focus on the use of specific compounds for the preparation of drugs aimed at inhibiting gastric acid secretion. The detailed formulations include 2-alkyl-4-arylmethylaminoquinolines of the general formula I, where R.sup.1, R.sup.2, R.sup.5, and R.sup.6 are defined in the claims, along with their physiologically tolerated salts.

Career Highlights

Klaus Ruebsamen has worked with prominent companies in the pharmaceutical industry, including BASF Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Ruebsamen has collaborated with esteemed colleagues such as Bernhard Schmied and Karl-Heinz Geiss. These partnerships have fostered a collaborative environment that has led to innovative solutions in pharmaceutical chemistry.

Conclusion

Klaus Ruebsamen's contributions to the field of pharmaceutical chemistry through his patents and collaborations highlight his role as a significant innovator. His work continues to influence the development of new drugs and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.